| Mrs Vimari Vega Rios, PSYD | |
|
Edificio Centurion Piso 3 Carr. #2 Km 11.8, Bayamon, PR 00961 | |
| (787) 995-2700 | |
| (787) 995-2706 |
| Full Name | Mrs Vimari Vega Rios |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | Edificio Centurion Piso 3 Carr. #2 Km 11.8, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013190008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Entity Name | Inspira Psychiatric Services Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346321668 PECOS PAC ID: 7517871767 Enrollment ID: O20031113000175 |
News Archive
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms. The discovery could lead to improved pharmaceutical treatment for type 2 diabetes and other obesity-related diseases.
A new study at Columbia University Mailman School of Public Health suggests there is a two-way relationship between bullying perpetration and mental health problems among youth in the U.S.
A campaign targeted at students arriving at university for the first time could hold the key to reducing the spread of meningitis and septicaemia, say researchers at the universities of Nottingham and Leicester.
An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.
Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults.
› Verified 4 days ago
| Entity Name | Inspira Behavioral Care Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063928596 PECOS PAC ID: 5294863262 Enrollment ID: O20141003000758 |
News Archive
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms. The discovery could lead to improved pharmaceutical treatment for type 2 diabetes and other obesity-related diseases.
A new study at Columbia University Mailman School of Public Health suggests there is a two-way relationship between bullying perpetration and mental health problems among youth in the U.S.
A campaign targeted at students arriving at university for the first time could hold the key to reducing the spread of meningitis and septicaemia, say researchers at the universities of Nottingham and Leicester.
An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.
Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Vimari Vega Rios, PSYD Aj12 Calle 26, Trujillo Alto, PR 00976-3424 Ph: (787) 381-9116 | Mrs Vimari Vega Rios, PSYD Edificio Centurion Piso 3 Carr. #2 Km 11.8, Bayamon, PR 00961 Ph: (787) 995-2700 |
News Archive
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms. The discovery could lead to improved pharmaceutical treatment for type 2 diabetes and other obesity-related diseases.
A new study at Columbia University Mailman School of Public Health suggests there is a two-way relationship between bullying perpetration and mental health problems among youth in the U.S.
A campaign targeted at students arriving at university for the first time could hold the key to reducing the spread of meningitis and septicaemia, say researchers at the universities of Nottingham and Leicester.
An analysis of published studies found no evidence that low- dose aspirin buffers against cognitive decline or dementia or improves cognitive test scores.
Rettsyndrome.org is pleased to share that Neuren Pharmaceuticals, today, after meeting with the FDA, will conduct a Phase 3 clinical trial for trofinetide, a compound that shows great promise in the treatment of Rett syndrome, in children and adults.
› Verified 4 days ago
Sandra I Quiles, PSYCHOLOGIST Psychologist Medicare: Medicare Enrolled Practice Location: Ave Santa Juanita, M-70 Ofc. #1, Bayamon, PR 00956 Phone: 787-449-6863 | |
Ms. Maria Rodriguez-isaac, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: A-2 # 1 Calle A, Urba Santa Elenita, Bayamon, PR 00957 Phone: 787-251-7310 | |
Myria A. Irizarry, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Be28 Calle Rio Amazonas, Urb.valle Verde,, Bayamon, PR 00961 Phone: 787-403-2899 | |
Dr. Maribeliz Diaz I, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Carr. #2, Antigua Facilidad De Mepsi Center. Bayamon, Bayamon, PR 00960 Phone: 787-723-7676 | |
Mrs. Maria Del Mar Torres, PH.D Psychologist Medicare: Medicare Enrolled Practice Location: B 10 # 4-2, Avenida Aguas Buenas, Bayamon, PR 00960 Phone: 787-647-8438 | |
Dr. Frances Lynn Centeno, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3b24 Ave Nogal, Lomas Verdes, Bayamon, PR 00956 Phone: 787-949-0758 |